Skip to main content

Modified Posterior Wall Ablation in Persistent Atrial Fibrillation: the BOX-AF Randomized Clinical Trial

In brief

Adding posterior wall ablation did not improve 12-month outcomes in persistent AF

Among 269 patients having their first catheter ablation for persistent atrial fibrillation, adding modified posterior wall ablation left 86.3% free of arrhythmia at 12 months, versus 86.9% with pulmonary vein isolation alone. The added ablation lengthened procedures, and similar adverse events occurred in both groups. Better outcomes after successful wall isolation came from a post-randomization analysis and do not establish cause and effect.

Journal
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (Q1)
Published
13 November 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Genqing Zhou, Xiaoyu Wu, Liangrong Zheng, Jingbo Li, Yunlong Xia, Zhiyu Lin, et al.
PMID
43023359
DOI
10.1093/europace/euag318

Why clinicians should know about it

Abstract

AIMS: The efficacy of left atrial posterior wall isolation (PWI) for persistent atrial fibrillation (AF) is controversial. We propose a modified left atrial posterior wall ablation strategy. OBJECTIVES: To evaluate the efficacy and safety of modified posterior wall ablation in patients with persistent AF who underwent first-time radiofrequency catheter ablation. METHODS AND RESULTS: In this multicenter, single-blind randomized trial, 276 patients with persistent AF were assigned 1:1 to pulmonary vein isolation (PVI) with (BOX+) or without modified posterior wall ablation (BOX-). Seven participants withdrew, leaving 269 (BOX+, n=139; BOX-, n=130) for primary endpoint analysis. The primary endpoint was freedom from any documented atrial arrhythmia lasting > 30 seconds without antiarrhythmic drugs after a 3 -month blanking period. At 12-month follow-up, the primary endpoint occurred in 120 of 139 patients (86.3%) in the BOX+ group and 113 of 130 (86.9%) in the BOX- group (hazard ratio 1.046, 95% CI, 0.54 - 2.01; P = 0.894). The BOX+ group exhibited longer procedure time and ablation time. Acute successful PWI was achieved in 91 (65.5%) patients assigned to BOX+. In a nonprespecified, post-randomization analysis, arrhythmia-free survival was 93.4% in patients with acute successful PWI, 72.9% in those with attempted but unsuccessful PWI, and 86.9% in controls without attempted PWI (overall log-rank P=0.002). Adverse events were similar between groups. CONCLUSION: Routine addition of modified posterior wall ablation did not improve overall outcomes of first-time ablation in persistent AF. However, achieving successful PWI was associated with significantly lower recurrence.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.